BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 3079355)

  • 1. [Immunologic deficit in Hodgkin's disease. Clinical reflections and pathogenetic implications].
    Maggi E; Romagnani S; Ricci M
    Ann Ital Med Int; 1986 Mar; 1(1):54-65. PubMed ID: 3079355
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunodeficiencies in Hodgkin's Disease. Part II: B cell immunity, complement systems and phagocytic cell systems.
    Gupta S
    Clin Bull; 1981; 11(3):110-9. PubMed ID: 7039866
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunodeficiencies in Hodgkin's disease. Part I: T cell-mediated immunity.
    Gupta S
    Clin Bull; 1981; 11(2):58-65. PubMed ID: 6459892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Splenectomy in lymphogranulomatosis].
    Simbirtseva LP
    Vopr Onkol; 1980; 26(3):97-102. PubMed ID: 6966108
    [No Abstract]   [Full Text] [Related]  

  • 5. Invited discussion: kinetic approach to the study of cell-mediated immunity in Hodgkin's disease.
    Hersh EM
    Natl Cancer Inst Monogr; 1973 May; 36():123-4. PubMed ID: 4744573
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunology in Hodgkin's disease.
    Gollerkeri MP
    Indian J Cancer; 1972 Dec; 9(4):312-5. PubMed ID: 4144182
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological aspects of lymphogranulomatosis].
    Blokhina NG; Agafonov VA; Bykovskaia SN; Naumova ER; Raushenbakh MO
    Ter Arkh; 1984; 56(10):125-30. PubMed ID: 6098042
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunology of Hodgkin's disease].
    Hoerni B; Chauvergne J; Hoerni-Simon G
    Bord Med; 1972 Jun; 5(11):1299-302. PubMed ID: 5054781
    [No Abstract]   [Full Text] [Related]  

  • 10. International symposium on Hodgkin's disease. Session 2. Histopathology and experimental cytology. Invited discussion: Synthesis and implications for the etiology, pathogenesis and spread of Hodgkin's disease.
    Berard CW
    Natl Cancer Inst Monogr; 1973 May; 36():261-3. PubMed ID: 4355349
    [No Abstract]   [Full Text] [Related]  

  • 11. [Impaired immunologic reactivity as pacemaker for lymphoma development (author's transl)].
    Krüger G
    Verh Dtsch Ges Pathol; 1971; 55():200-4. PubMed ID: 4130717
    [No Abstract]   [Full Text] [Related]  

  • 12. International Symposium on Hodgkin's disease. Session 1. Epidemiology and etiology. Part 4. Synthesis and epidemiological implications. Invited discussion: Synthesis and epidemiologic implications.
    Miller RW
    Natl Cancer Inst Monogr; 1973 May; 36():171-2. PubMed ID: 4270377
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunity in Hodgkin's lymphoma].
    Danieli G; Montroni M; Leoni P; Magelli L; Totti S
    G Clin Med; 1975; 56(1):39-56. PubMed ID: 770222
    [No Abstract]   [Full Text] [Related]  

  • 14. The immunohistology of Hodgkin's disease--Reed-Sternberg cells and their variants.
    Angel CA; Warford A; Campbell AC; Pringle JH; Lauder I
    J Pathol; 1987 Sep; 153(1):21-30. PubMed ID: 3499498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses to tests of cell mediated immunity before, during and after BCG administration in Hodgkin's disease.
    Lenzini L; Bracci R; Rottoli P; Rottoli L
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:300. PubMed ID: 4546904
    [No Abstract]   [Full Text] [Related]  

  • 16. [Subpopulations of immunocompetent cells in patients with liver cirrhosis studied using monoclonal antibodies].
    Podymova SD; Rachvelishvili NB; Tabagari DZ
    Ter Arkh; 1988; 60(11):49-53. PubMed ID: 3266373
    [No Abstract]   [Full Text] [Related]  

  • 17. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
    Fisher RI
    Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The target cell for antilymphocyte antibodies in Hodgkin's disease].
    Del Giacco GS; Manconi PE; Tognella S; Mantovani G; Turno R; Grifoni V
    Boll Ist Sieroter Milan; 1974; 53(4):562-4. PubMed ID: 4615725
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hodgkin's disease. Histology--immunohistology--immunology].
    Möller P
    Norm Pathol Anat (Stuttg); 1986; 51():1-77. PubMed ID: 3495783
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hodgkin's disease--an atypical immune reaction].
    Trepel F; Schick P
    Med Klin; 1977 Jun; 72(23):1003-18. PubMed ID: 327241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.